1. Home
  2. VERA vs MEOH Comparison

VERA vs MEOH Comparison

Compare VERA & MEOH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vera Therapeutics Inc.

VERA

Vera Therapeutics Inc.

HOLD

Current Price

$35.49

Market Cap

3.2B

Sector

Health Care

ML Signal

HOLD

Logo Methanex Corporation

MEOH

Methanex Corporation

HOLD

Current Price

$61.59

Market Cap

3.8B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
VERA
MEOH
Founded
2016
1968
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
3.8B
IPO Year
2021
1995

Fundamental Metrics

Financial Performance
Metric
VERA
MEOH
Price
$35.49
$61.59
Analyst Decision
Strong Buy
Buy
Analyst Count
10
9
Target Price
$81.30
$58.33
AVG Volume (30 Days)
1.1M
1.4M
Earning Date
05-06-2026
04-29-2026
Dividend Yield
N/A
1.17%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$25.43
Revenue Next Year
$472.48
N/A
P/E Ratio
N/A
$16.44
Revenue Growth
N/A
N/A
52 Week Low
$18.76
$31.57
52 Week High
$56.05
$66.75

Technical Indicators

Market Signals
Indicator
VERA
MEOH
Relative Strength Index (RSI) 37.97 52.41
Support Level $22.10 $46.36
Resistance Level $42.77 $66.75
Average True Range (ATR) 1.83 2.07
MACD -0.34 0.05
Stochastic Oscillator 16.98 62.96

Price Performance

Historical Comparison
VERA
MEOH

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

About MEOH Methanex Corporation

Methanex Corp manufactures and sells methanol. Its customers use methanol as a feedstock to produce end-products including adhesives, foams, solvents, and windshield washer fluids. The firm also sells its products to the oil refining industry, where the methanol is blended with gasoline to produce a high-octane fuel or blended as a component of biodiesel. It distributes its products through an extensive supply chain that includes the operation of port terminals, tankers, barges, rail cars, trucks, and pipelines. The company generates the majority of its revenue from Europe.

Share on Social Networks: